Aurora Cannabis Files 6-K for Q1 2025

Ticker: ACB · Form: 6-K · Filed: 2024-08-07T00:00:00.000Z

Sentiment: neutral

Topics: regulatory-filing, 6-K, foreign-private-issuer

TL;DR

Aurora Cannabis filed a 6-K, confirming they're using Form 40-F for annual reports.

AI Summary

Aurora Cannabis Inc. filed a Form 6-K on August 7, 2024, for the period ending June 30, 2024. This report is incorporated by reference into their F-10 registration statement (File No. 333-271479). The filing indicates Aurora Cannabis Inc. is a foreign private issuer and will file annual reports under Form 40-F.

Why It Matters

This filing provides an update on Aurora Cannabis Inc.'s reporting status and incorporates previous filings into their F-10 registration statement, which is relevant for investors tracking the company's regulatory compliance and financial disclosures.

Risk Assessment

Risk Level: low — This filing is primarily procedural and informational, with no immediate financial or operational risks indicated.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing?

The primary purpose is to report information that Aurora Cannabis Inc. has made or is required to make public in Canada, and to incorporate this report by reference into their existing F-10 registration statement.

Which form will Aurora Cannabis Inc. use for its annual reports?

Aurora Cannabis Inc. will file its annual reports under cover of Form 40-F.

What period does this Form 6-K cover?

This Form 6-K covers the period of report ending on June 30, 2024.

What is the SEC file number for Aurora Cannabis Inc.?

The SEC file number for Aurora Cannabis Inc. is 001-38691.

Is this filing being submitted in paper format?

The filing does not indicate submission in paper format, as indicated by the unchecked boxes for Regulation S-T Rule 101(b)(1) and 101(b)(7).

From the Filing

0001683541-24-000015.txt : 20240807 0001683541-24-000015.hdr.sgml : 20240807 20240807071512 ACCESSION NUMBER: 0001683541-24-000015 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240807 DATE AS OF CHANGE: 20240807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AURORA CANNABIS INC CENTRAL INDEX KEY: 0001683541 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38691 FILM NUMBER: 241181418 BUSINESS ADDRESS: STREET 1: 2207 90B STREET SW CITY: EDMONTON STATE: A0 ZIP: T6X 1V8 BUSINESS PHONE: 604-362-5207 MAIL ADDRESS: STREET 1: 409 GRANVILLE STREET STREET 2: SUITE 1700 CITY: VANCOUVER STATE: A1 ZIP: V6C 1T2 6-K 1 form6-k20240630q12025.htm 6-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F Form 20-F   [ ] Form 40-F  [X] Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)  [ ] Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)  [ ] This Form 6-K is hereby filed and incorporated by reference in the registrant’s Registration Statement on Form F-10 (File No. 333-271479). SUBMITTED HEREWITH Exhibits Description 99.1 Condensed Consolidated Interim Financial Statements for the three months ended June 30, 2024 and 2023 99.2 Interim Management’s Discussion and Analysis for the three months ended June 30, 2024 and 2023 99.3 Certification of Chief Executive Officer 99.4 Certification of Chief Financial Officer      SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AURORA CANNABIS INC. /s/ Simona King              Simona King Chief Financial Officer Date: August 7, 2024      EX-99.1 2 fs20240630q12025.htm EX-99.1 Document AURORA CANNABIS INC. Condensed Consolidated Interim Financial Statements (Unaudited) For the three months ended June 30, 2024 and 2023 (in Canadian Dollars) Table of Contents Condensed Consolidated Interim Statements of Financial Position 3 Condensed Consolidated Interim Statements of Income (Loss) and Comprehensive Income (Loss) 4 Condensed Consolidated Interim Statements of Changes in Equity 6 Condensed Consolidated Interim Statements of Cash Flows 8 Notes to the Condensed Consolidated Interim Financial Statements Note 1 Nature of Operations 9 Note 11 Share-Based Compensation 18 Note 2 Material Accounting Policies and Judgments 9 Note 12 Income (Loss) per share 20 Note 3 Biological Assets 11 Note 13 Supplemental Cash Flow Information 21 Note 4 Inventory 12 Note 14 Commitments and Contingencies 21 Note 5 Property, Plant and Equipment 13 Note 15 Revenue 23 Note 6 Assets and Liabilities Held for Sale and Discontinued Operations 14 Note 16 Segmented Information 24 Note 7 Intangible Assets and Goodwill 15 Note 17 Fair Value of Financial Instruments 25 Note 8 Loans and Borrowings 16 Note 18 Financial Instruments Risk 25 Note 9 Lease Liabilities 17 Note 19 Subsequent Events 26 Note 10 Share Capital 17 AURORA CANNABIS INC

View on Read The Filing